Search / Trial NCT04298450

ED to EPI: Using SMS to Improve the Transition from the Emergency Department to Early Psychosis Intervention
Launched by CENTRE FOR ADDICTION AND MENTAL HEALTH · Mar 4, 2020

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Early Psychosis Intervention Mobile Health Intervention Patient And Family Engagement Pragmatic Clinical Trials Transitions In Care

ClinConnect Summary

This clinical trial, called "ED to EPI," is studying how text messaging can help young people who are experiencing psychosis transition more smoothly from the emergency department to specialized early intervention services. Psychosis is a serious mental health condition that often starts in young adulthood, and many young people struggle to get the help they need until their situation becomes critical. By using SMS (text messages) to keep in touch with participants, the researchers hope to encourage them to attend their first appointments and stay engaged with treatment over time.

To participate in this study, individuals must be referred to the early psychosis intervention program from the emergency department of the Centre for Addiction and Mental Health (CAMH) due to suspected psychosis. Those who can communicate in basic written English are eligible. Participants can expect to receive supportive text messages that aim to help them navigate their care, and the study will also look at how effective and cost-efficient this approach is. Overall, this trial is focused on improving access to mental health services for young people during a critical time in their treatment journey.

Gender

ALL

Eligibility criteria

Inclusion Criteria:
• Have been referred by the Centre for Addiction and Mental Health (CAMH) emergency department or related acute services to the CAMH early psychosis intervention (EPI) program for suspected psychosis
Exclusion Criteria:
• Inability to communicate in basic written English

About Centre For Addiction And Mental Health

The Centre for Addiction and Mental Health (CAMH) is Canada’s leading mental health and addiction teaching hospital, dedicated to advancing research, clinical care, and education in the field of mental health. With a commitment to improving the lives of individuals affected by mental illness and addiction, CAMH conducts innovative clinical trials aimed at developing and evaluating new treatment approaches. The institution fosters a collaborative environment that brings together researchers, clinicians, and community partners to translate scientific findings into effective interventions, ensuring the highest standards of care and support for patients. Through its robust research initiatives, CAMH strives to enhance understanding of mental health disorders and promote evidence-based practices in the treatment of addiction and mental health challenges.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Nicole Kozloff, MD, SM

Principal Investigator